Reply to: "Efficacy and safety of doxycycline versus iodopovidone for pleurodesis through an intercostal tube in malignant pleural effusions: a randomized trial".

Yuki Yoshimatsu, Yasushi Tsujimoto, Yasuaki Tomioka

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2024;32(7):453

PMID: 38909347

Full Text on Springer View on PubMed

Abstract

Address: Division of Thoracic Surgery, Department of Surgery, Fukuyama City Hospital, 5-23-1 Zao-cho, Fukuyama, Hiroshima, 721-8511, Japan. [email protected].; Elderly Care, Queen Elizabeth Hospital, Lewisham and Greenwich NHS Trust, Stadium Rd, London, SE18 4QH, UK.; Centre for Exercise Activity and Rehabilitation, School of Human Sciences, University of Greenwich, Avery Hill Rd, London, SE9 2HB, UK.; Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan.; Scientific Research WorkS Peer Support Group (SRWS-PSG), Osaka, Japan.; Oku Medical Clinic, Shimmori, Osaka, Japan.; Department of Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health, Kyoto University, Yoshida Konoe-cho, Sakyo-ku, Kyoto, Japan.

DOI: 10.1007/s00520-024-08670-5

Link outs

Subscription / membership required

Full Text Sources:

https://dx.doi.org/10.1007/s00520-024-08670-5

MeSH Terms: Humans, Pleural Effusion, Malignant, Pleurodesis, Povidone-Iodine, Doxycycline, Chest Tubes, Randomized Controlled Trials as Topic, Anti-Bacterial Agents